Bank of New York Mellon’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.76M | Buy |
377,127
+16,803
| +5% | +$78.5K | ﹤0.01% | 2802 |
|
|
2025
Q1 | $1.98M | Buy |
360,324
+37,949
| +12% | +$208K | ﹤0.01% | 2684 |
|
|
2024
Q4 | $1.09M | Sell |
322,375
-6,873
| -2% | -$23.3K | ﹤0.01% | 3088 |
|
|
2024
Q3 | $938K | Sell |
329,248
-99,306
| -23% | -$283K | ﹤0.01% | 3167 |
|
|
2024
Q2 | $964K | Buy |
428,554
+80,015
| +23% | +$180K | ﹤0.01% | 3220 |
|
|
2024
Q1 | $770K | Sell |
348,539
-21,903
| -6% | -$48.4K | ﹤0.01% | 3285 |
|
|
2023
Q4 | $871K | Sell |
370,442
-42,501
| -10% | -$99.9K | ﹤0.01% | 3260 |
|
|
2023
Q3 | $768K | Sell |
412,943
-11,411
| -3% | -$21.2K | ﹤0.01% | 3317 |
|
|
2023
Q2 | $1.11M | Buy |
424,354
+13,160
| +3% | +$34.5K | ﹤0.01% | 3131 |
|
|
2023
Q1 | $670K | Buy |
411,194
+388
| +0.1% | +$632 | ﹤0.01% | 3331 |
|
|
2022
Q4 | $546K | Sell |
410,806
-307
| -0.1% | -$408 | ﹤0.01% | 3496 |
|
|
2022
Q3 | $642K | Buy |
411,113
+35,112
| +9% | +$54.8K | ﹤0.01% | 3445 |
|
|
2022
Q2 | $579K | Buy |
376,001
+280,131
| +292% | +$431K | ﹤0.01% | 3500 |
|
|
2022
Q1 | $245K | Hold |
95,870
| – | – | ﹤0.01% | 4131 |
|
|
2021
Q4 | $281K | Buy |
95,870
+40,725
| +74% | +$119K | ﹤0.01% | 4126 |
|
|
2021
Q3 | $135K | Buy |
55,145
+11,534
| +26% | +$28.2K | ﹤0.01% | 4269 |
|
|
2021
Q2 | $177K | Sell |
43,611
-122,231
| -74% | -$496K | ﹤0.01% | 4121 |
|
|
2021
Q1 | $747K | Sell |
165,842
-311
| -0.2% | -$1.4K | ﹤0.01% | 3484 |
|
|
2020
Q4 | $818K | Buy |
166,153
+50,806
| +44% | +$250K | ﹤0.01% | 3361 |
|
|
2020
Q3 | $684K | Buy |
115,347
+12,513
| +12% | +$74.2K | ﹤0.01% | 3330 |
|
|
2020
Q2 | $273K | Buy |
102,834
+2,858
| +3% | +$7.59K | ﹤0.01% | 3716 |
|
|
2020
Q1 | $195K | Buy |
99,976
+16,624
| +20% | +$32.4K | ﹤0.01% | 3741 |
|
|
2019
Q4 | $588K | Buy |
83,352
+6,648
| +9% | +$46.9K | ﹤0.01% | 3508 |
|
|
2019
Q3 | $754K | Sell |
76,704
-228,070
| -75% | -$2.24M | ﹤0.01% | 3321 |
|
|
2019
Q2 | $3.49M | Buy |
304,774
+9,491
| +3% | +$109K | ﹤0.01% | 2505 |
|
|
2019
Q1 | $2.97M | Buy |
295,283
+275,342
| +1,381% | +$2.76M | ﹤0.01% | 2579 |
|
|
2018
Q4 | $339K | Buy |
19,941
+5,027
| +34% | +$85.5K | ﹤0.01% | 3662 |
|
|
2018
Q3 | $262K | Buy |
+14,914
| New | +$262K | ﹤0.01% | 3853 |
|